Kodiak Sciences (KOD) Gains from Sales and Divestitures (2017 - 2025)
Kodiak Sciences (KOD) reported Gains from Sales and Divestitures of $45190.0 for Q4 2025, down 47.79% on a YoY basis from $86559.0 in Q4 2024, and up 828.12% quarter-over-quarter from $4869.0 in Q3 2025.
Kodiak Sciences (KOD) Gains from Sales and Divestitures (2017 - 2025) Analysis & Trends
Kodiak Sciences has reported Gains from Sales and Divestitures for 8 years, with the latest figure at $45190.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Sales and Divestitures fell 47.79% year-over-year to $45190.0; the trailing twelve-month figure through Dec 2025 stood at $45190.0 (down 47.79% YoY), and the FY2025 full-year result was $45190.0, down 47.79% from the prior year.
- Gains from Sales and Divestitures for Q4 2025 stood at $45190.0, up from $4869.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $116403.0 in Q4 2023, with the low at $3532.0 in Q1 2025.
- Historically, Gains from Sales and Divestitures has averaged $56057.9 across 5 years, with a median of $70988.0 in 2024.
- Annual changes were most pronounced in 2022 — Gains from Sales and Divestitures jumped 214.57% — and 2025, when it slumped 93.86%.
- Kodiak Sciences' Gains from Sales and Divestitures stood at $93218.0 in 2021, then increased by 10.53% to $103032.0 in 2022, then advanced by 12.98% to $116403.0 in 2023, then dropped by 25.64% to $86559.0 in 2024, then sank by 47.79% to $45190.0 in 2025.
- The last three Gains from Sales and Divestitures figures came in at $45190.0 (Q4 2025), $4869.0 (Q3 2025), and $29593.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 45,190.00 |
| Dec 31, 2025 | 45,190.00 |
| Sep 30, 2025 | 4,869.00 |
| Sep 30, 2025 | 4,869.00 |
| Jun 30, 2025 | 29,593.00 |
| Jun 30, 2025 | 29,593.00 |
| Mar 31, 2025 | 3,532.00 |
| Mar 31, 2025 | 3,532.00 |
| Dec 31, 2024 | 86,559.00 |
| Dec 31, 2024 | 86,559.00 |
| Sep 30, 2024 | 79,346.00 |
| Sep 30, 2024 | 79,346.00 |
| Jun 30, 2024 | 70,988.00 |
| Jun 30, 2024 | 70,988.00 |
| Mar 31, 2024 | 6,512.00 |
| Mar 31, 2024 | 6,512.00 |
| Dec 31, 2023 | 116,403.00 |
| Dec 31, 2023 | 116,403.00 |
| Sep 30, 2023 | 100,073.00 |
| Sep 30, 2023 | 100,073.00 |